Caladrius Biosciences Inc Stock Nasdaq
Equities
US1280581042
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 30.74M 42.07M |
---|---|---|---|---|---|
Net income 2024 * | -25M -34.21M | Net income 2025 * | -30M -41.06M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.2
x | P/E ratio 2025 * |
-1.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.21% |
Latest transcript on Caladrius Biosciences Inc
1st Jan change | Capi. | |
---|---|---|
+23.62% | 47.96B | |
+0.20% | 42.45B | |
+43.96% | 41.47B | |
+25.87% | 31.6B | |
+19.48% | 28.63B | |
-4.47% | 28.03B | |
+51.39% | 14.56B | |
+44.08% | 14.14B | |
+1.94% | 12.58B |